4-Hydroxytamoxifen-stimulated processing of cyclin E is mediated via G protein-coupled receptor 30 (GPR30) and accompanied by enhanced migration in MCF-7 breast cancer cells

Toxicology

Volumn 309, Issue , 2013, Pages 61-65

  Li, Yang ^a   Chen, Yan ^a   Zhu, Zhu Xia ^a   Liu, Xiao Hong ^a   Yang, Li ^a   Wan, Lei ^a   Lei, Ting Wen ^a   Wang, Xu Dong ^a  

^a GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Cyclin E; G protein coupled receptor 30 (GPR30); Migration; Tamoxifen

Indexed keywords

AFIMOXIFENE; CYCLIN E; ESTROGEN RECEPTOR ALPHA; G PROTEIN COUPLED RECEPTOR 30; SMALL INTERFERING RNA;

ARTICLE; BREAST CANCER; CANCER CELL; CELL MIGRATION; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CELL MOVEMENT; CYCLIN E; FEMALE; HUMANS; MCF-7 CELLS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; TAMOXIFEN; UP-REGULATION;

EID: 84878155024     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2013.04.012     Document Type: Article

References (24)

1. Akli S., Van Pelt C.S., Bui T., Multani A.S., Chang S., Johnson D., Tucker S., Keyomarsi K. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway. Cancer Res. 2007, 67:7212-7222.
2. Akli S., Zheng P.J., Multani A.S., Wingate H.F., Pathak S., Zhang N., Tucker S.L., Chang S., Keyomarsi K. Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer. Cancer Res. 2004, 64:3198-3208.
3. Carmeci C., Thompson D.A., Ring H.Z., Francke U., Weigel R.J. Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics 1997, 45:607-617.
4. Du G.Q., Zhou L., Chen X.Y., Wan X.P., He Y.Y. The G protein-coupled receptor GPR30 mediates the proliferative and invasive effects induced by hydroxytamoxifen in endometrial cancer cells. Biochem. Biophys. Res. Commun. 2012, 420:343-349.
5. Filardo E.J., Quinn J.A., Sabo E. Association of the membrane estrogen receptor, GPR30, with breast tumor metastasis and transactivation of the epidermal growth factor receptor. Steroids 2008, 73:870-873.
6. Filardo E.J., Quinn J.A., Bland K.I., Frackelton A.R. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog. GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 2000, 14:1649-1660.
7. Helmestam M., Andersson H., Stavreus-Evers A., Brittebo Olovsson M. Tamoxifen modulates cell migration and expression of angiogenesis-related genes in human endometrial endothelial cells. Am. J. Pathol. 2012, 180:2527-2535.
8. Hou J., Wang X., Li Y., Liu X., Wang Z., An J., Yang L., He Y. 17Beta-estradiol induces both up-regulation and processing of cyclin E in a calpain-dependent manner in MCF-7 breast cancer cells. FEBS Lett. 2012, 586:892-896.
9. Ignatov A., Ignatov T., Roessner A., Costa S.D., Kalinski T. Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells. Breast Cancer Res. Treat. 2010, 123:87-96.
10. Ignatov A., Ignatov T., Weissenborn C., Eggemann H., Bischoff J., Semczuk A., Roessner A., Costa S.D., Kalinski T. G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer. Breast Cancer Res. Treat. 2011, 128:457-466.
11. Koff A., Giordano A., Desai D., Yamashita K., Harper J.W., Elledge S., Nishimoto T., Morgan D.O., Franza B.R., Roberts J.M. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 1992, 257:1689-1694.
12. Keyomarsi K., Conte D., Toyofuku W., Fox M.P. Deregulation of cyclin E in breast cancer. Oncogene 1995, 11:941-950.
13. Keyomarsi K., Tucker S.L., Buchholz T.A., Callister M., Ding Y., Hortobagyi G.N., Bedrosian I., Knickerbocker C., Toyofuku W., Lowe M., Herliczek T.W., Bacus S.S. Cyclin E and survival in patients with breast cancer. N. Engl. J. Med. 2002, 347:1566-1575.
14. Libertini S.J., Robinson B.S., Dhillon N.K., Glick D., George M., Dandekar S., Gregg J.P., Sawai E., Mudryj M. Cyclin E both regulates and is regulated by calpain 2 a protease associated with metastatic breast cancer phenotype. Cancer Res. 2005, 65:10700-10708.
15. Lappano R., Rosano C., De Marco P., De Francesco E.M., Pezzi V., Maggiolini M. Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells. Mol. Cell Endocrinol. 2010, 320:162-170.
16. Liang Y., Gao H., Lin S.Y., Goss J.A., Brunicardi F.C., Li K. siRNA-based targeting of cyclin E overexpression inhibits breast cancer cell growth and suppresses tumor development in breast cancer mouse model. PLoS One 2010, 5:e12860.
17. Lin B.C., Suzawa M., Blind R.D., Tobias S.C., Bulun S.E., Scanlan T.S., Ingraham H.A. Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation. Cancer Res. 2009, 69:5415-5423.
18. Pandey D.P., Lappano R., Albanito L., Madeo A., Maggiolini M., Picard D. Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF. EMBO J. 2009, 28:523-532.
19. Peyre L., Zucchini-Pascal N., de Sousa G., Rahmani R. Effects of endosulfan on hepatoma cell adhesion: Epithelial-mesenchymal transition and anoikis resistance. Toxicology 2012, 300:19-30.
20. Ruan S.Q., Wang Z.H., Wang S.W., Fu Z.X., Xu K.L., Li D.B., Zhang S.Z. Heregulin-β1-induced GPR30 upregulation promotes the migration and invasion potential of SkBr3 breast cancer cells via ErbB2/ErbB3-MAPK/ERK pathway. Biochem. Biophys. Res. Commun. 2012, 420:385-390.
21. Shanle E.K., Xu W. Selectively targeting estrogen receptors for cancer treatment. Adv. Drug Deliv. Rev. 2010, 62:1265-1276.
22. Vivacqua A., Bonofiglio D., Recchia A.G., Musti A.M., Picard D., Andò S., Maggiolini M. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells. Mol. Endocrinol. 2006, 20:631-646.
23. Wang X.D., Rosales J.L., Magliocco A., Gnanakumar R., Lee K.Y. Cyclin E in breast tumors is cleaved into its low molecular weight forms by calpain. Oncogene 2003, 22:769-774.
24. Wingate H., Puskas A., Duong M., Bui T., Richardson D., Liu Y., Tucker S.L., Van Pelt C., Meijer L., Hunt K., Keyomarsi K. Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression. Cell Cycle 2009, 8:1062-1068.